Go Pro

Tilray Brands (TLRY) Competitors

Tilray Brands logo
$3.58 +0.02 (+0.42%)
As of 01:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.

TLRY vs. ACB, CGC, CRON, OGI, and SNDL

Should you buy Tilray Brands stock or one of its competitors? Tilray Brands's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), and SNDL (SNDL). Companies are selected based on similarities in market, industry, and size.

How does Tilray Brands compare to Aurora Cannabis?

Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Tilray Brands has a net margin of -13.11% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
Aurora Cannabis -32.26%4.37%3.45%

Tilray Brands has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Tilray Brands presently has a consensus target price of $7.00, indicating a potential upside of 95.26%. Given Tilray Brands' higher probable upside, equities analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.29
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.53-$121.40M-$1.08N/A
Aurora Cannabis$247.82M1.04-$88.13M-$1.41N/A

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.8% of Tilray Brands shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Tilray Brands had 18 more articles in the media than Aurora Cannabis. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.40 beat Aurora Cannabis' score of -0.81 indicating that Tilray Brands is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
4 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Negative

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Canopy Growth?

Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

Tilray Brands has higher revenue and earnings than Canopy Growth. Tilray Brands is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.53-$121.40M-$1.08N/A
Canopy Growth$251.01M1.56-$190.29M-$0.45N/A

In the previous week, Tilray Brands and Tilray Brands both had 21 articles in the media. Canopy Growth's average media sentiment score of 0.93 beat Tilray Brands' score of 0.40 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
4 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Canopy Growth
14 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray Brands has a net margin of -13.11% compared to Canopy Growth's net margin of -65.33%. Tilray Brands' return on equity of -7.76% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
Canopy Growth -65.33%-21.91%-14.34%

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Comparatively, 0.4% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Tilray Brands has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Tilray Brands presently has a consensus target price of $7.00, suggesting a potential upside of 95.26%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities research analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.29
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

Tilray Brands beats Canopy Growth on 11 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Cronos Group has a net margin of 39.08% compared to Tilray Brands' net margin of -13.11%. Cronos Group's return on equity of 4.85% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
Cronos Group 39.08%4.85%4.62%

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.53-$121.40M-$1.08N/A
Cronos Group$146.59M8.13-$9.45M$0.2016.18

Tilray Brands has a beta of 1.91, suggesting that its share price is 91% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.86 beat Tilray Brands' score of 0.40 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
4 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray Brands presently has a consensus price target of $7.00, indicating a potential upside of 95.26%. Cronos Group has a consensus price target of $2.30, indicating a potential downside of 28.90%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.29
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

Cronos Group beats Tilray Brands on 11 of the 17 factors compared between the two stocks.

How does Tilray Brands compare to Organigram Global?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Tilray Brands currently has a consensus price target of $7.00, indicating a potential upside of 95.26%. Given Tilray Brands' higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.29
Organigram Global
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Tilray Brands had 18 more articles in the media than Organigram Global. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.16 beat Tilray Brands' score of 0.40 indicating that Organigram Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
4 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Organigram Global
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Tilray Brands has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market.

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.53-$121.40M-$1.08N/A
Organigram Global$185.07M0.73-$17.70M$0.462.09

Organigram Global has a net margin of 28.14% compared to Tilray Brands' net margin of -13.11%. Tilray Brands' return on equity of -7.76% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
Organigram Global 28.14%-13.39%-8.67%

Summary

Tilray Brands and Organigram Global tied by winning 8 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to SNDL?

Tilray Brands (NASDAQ:TLRY) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

SNDL has lower revenue, but higher earnings than Tilray Brands. SNDL is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.53-$121.40M-$1.08N/A
SNDL$677.32M0.48-$11.29M-$0.06N/A

Tilray Brands has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market. Comparatively, SNDL has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

SNDL has a net margin of -2.36% compared to Tilray Brands' net margin of -13.11%. SNDL's return on equity of -2.01% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
SNDL -2.36%-2.01%-1.67%

9.4% of Tilray Brands shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Tilray Brands had 20 more articles in the media than SNDL. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for SNDL. Tilray Brands' average media sentiment score of 0.40 beat SNDL's score of 0.30 indicating that Tilray Brands is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
4 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
SNDL
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tilray Brands presently has a consensus price target of $7.00, suggesting a potential upside of 95.26%. Given Tilray Brands' stronger consensus rating and higher possible upside, equities analysts clearly believe Tilray Brands is more favorable than SNDL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.29
SNDL
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

Tilray Brands beats SNDL on 12 of the 17 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$488.28M$12.22B$7.12B$13.24B
Dividend YieldN/A2.63%2.53%15.88%
P/E Ratio-3.32799.70274.2126.08
Price / Sales0.53751.82607.9392.41
Price / CashN/A81.7977.3851.25
Price / Book0.2610.3110.926.30
Net Income-$121.40M$2.84B$3.50B$361.41M
7 Day Performance-13.20%-1.78%-2.09%-1.55%
1 Month Performance-20.69%-6.04%-6.33%-3.80%
1 Year Performance-77.73%-3.73%9.10%2.92%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
3.8638 of 5 stars
$3.59
+0.4%
$7.00
+95.3%
-78.4%$488.28M$915.45MN/A3,595
ACB
Aurora Cannabis
0.9867 of 5 stars
$4.04
-1.3%
N/A-31.9%$261.63M$247.82MN/A1,028
CGC
Canopy Growth
0.9529 of 5 stars
$0.93
+0.2%
N/A-36.1%$416.50M$251.01MN/A1,128
CRON
Cronos Group
1.376 of 5 stars
$3.39
-0.7%
$2.30
-32.1%
+20.7%$1.25B$146.59M16.93610
OGI
Organigram Global
2.5452 of 5 stars
$1.06
-2.8%
N/A-48.6%$148.80M$185.07M2.291,139

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners